Literature DB >> 28658764

Evaluation of Histologically and Histochemically Proven Cases of Vitiligo and its Correlation with CD4+ and CD8+ Lymphocyte Counts using Flow Cytometry.

Moninder Kaur1, Permeet Kaur Bagga2, Tejinder Kaur3, Amarjit Singh Kataria4.   

Abstract

INTRODUCTION: Vitiligo is an acquired cutaneous disorder characterized by progressive and selective destruction of melanocytes from the epidermis. Autoimmunity is strongly implicated in its pathogenesis. The destruction of melanocytes has a correlation with the peripheral blood lymphocyte imbalance mainly including Cytotoxic T cells (CD8+cells) and Helper T cells (CD4+cells). The progression of vitiligo is associated with higher CD8+ counts and lower CD4+ counts thus, altering CD4+: CD8+ ratio. AIM: To evaluate the clinically suspected cases of vitiligo histopathologically and histochemically and to establish the co-relation of autoimmunity with the flow cytometric analysis of CD8+ and CD4+ lymphocyte counts.
MATERIALS AND METHODS: In this study, 40 patients with proven vitiligo were taken. The destruction of melanocytes was confirmed by Haematoxylin & Eosin (H & E) and by histochemical stains using Dihydroxyphenylacetic Acid (DOPA) reaction. Blood sample from these vitiligo patients and 10 control subjects was taken. Flow Cytometry was used for the determination of CD8+ and CD4+ counts in the vitiligo patients and control subjects. Then CD4+: CD8+ ratio was calculated and comparison between vitiligo patients and control subjects was done. T-test was used for the statistical analysis.
RESULTS: There was statistically significant decrease in CD4+: CD8+ ratio. CD4+: CD8+ ratio was decreased in 57.5% cases of vitiligo with increase in CD8+ counts and decreased CD4+ counts.
CONCLUSION: It was concluded from this study that cellular immunity might have a role to play in the pathogenesis of vitiligo causing the destruction of melanocytes.

Entities:  

Keywords:  Cellular; Depigmentation; Immunity; Melanin

Year:  2017        PMID: 28658764      PMCID: PMC5483666          DOI: 10.7860/JCDR/2017/25665.9821

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  21 in total

1.  Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families.

Authors:  Asem Alkhateeb; Pamela R Fain; Anthony Thody; Dorothy C Bennett; Richard A Spritz
Journal:  Pigment Cell Res       Date:  2003-06

2.  In vitro studies on vitiligo.

Authors:  F HU; R P FOSNAUGH; P F LESNEY
Journal:  J Invest Dermatol       Date:  1959-11       Impact factor: 8.551

3.  The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force.

Authors:  Alain Taïeb; Mauro Picardo
Journal:  Pigment Cell Res       Date:  2007-02

4.  Clinical and sociodemographic study of vitiligo.

Authors:  Hita Shah; Anil Mehta; Bhavesh Astik
Journal:  Indian J Dermatol Venereol Leprol       Date:  2008 Nov-Dec       Impact factor: 2.545

5.  Flow cytometric analysis of peripheral blood lymphocytes in patients with vitiligo.

Authors:  Abeer Sheneef; Dawela Reham Ezz-El; Tamer M Mahmoud
Journal:  Egypt J Immunol       Date:  2012

6.  Aberrations in T lymphocytes and natural killer cells in vitiligo: a flow cytometric study.

Authors:  R M Halder; C S Walters; B A Johnson; S G Chakrabarti; J A Kenney
Journal:  J Am Acad Dermatol       Date:  1986-05       Impact factor: 11.527

7.  Late onset vitiligo: a study of 182 patients.

Authors:  Sunil Dogra; Davinder Parsad; Sanjeev Handa; Amrinder Jit Kanwar
Journal:  Int J Dermatol       Date:  2005-03       Impact factor: 2.736

8.  T cell profiles in vitiligo.

Authors:  P E Grimes; M Ghoneum; T Stockton; C Payne; A P Kelly; L Alfred
Journal:  J Am Acad Dermatol       Date:  1986-02       Impact factor: 11.527

9.  Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo.

Authors:  Anna Wańkowicz-Kalińska; René M J G J van den Wijngaard; Bert J Tigges; Wiete Westerhof; Graham S Ogg; Vincenzo Cerundolo; Walter J Storkus; Pranab K Das
Journal:  Lab Invest       Date:  2003-05       Impact factor: 5.662

10.  Clinical patterns of vitiligo and its associated co morbidities: A prospective controlled cross-sectional study in South India.

Authors:  D S Krupa Shankar; K Shashikala; Rama Madala
Journal:  Indian Dermatol Online J       Date:  2012-05
View more
  2 in total

1.  Nivolumab induced vitiligo-like lesions in a patient with metastatic squamous cell carcinoma of the lung.

Authors:  Kazumi Nishino; Shuichi Ohe; Masanori Kitamura; Kei Kunimasa; Madoka Kimura; Takako Inoue; Motohiro Tamiya; Toru Kumagai; Shin-Ichi Nakatsuka; Taiki Isei; Fumio Imamura
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

2.  Effect of vitiligo treatment by compound Glycyrrhizin combined with fractional laser and Triamcinolone Acetonide injection on T Lymphocyte subpopulation.

Authors:  Ling Li; Lei Gao; Yifan Zhao
Journal:  Pak J Med Sci       Date:  2022 Jan-Feb       Impact factor: 1.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.